SCRI Oncology Partners - PPDS — Nashville, Tennessee

SCRI Oncology Partners - PPDS is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners - PPDS has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Sponsors: Pierre Fabre Medicament, Recursion Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners - PPDS?

SCRI Oncology Partners - PPDS has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners - PPDS conducted?

SCRI Oncology Partners - PPDS has 2 clinical trials on record, with 2 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Is SCRI Oncology Partners - PPDS accredited by Crixeo Health?

SCRI Oncology Partners - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.